Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Q In postmenopausal women with osteoporosis, is strontium ranelate more effective than placebo for reducing the risk of vertebral fractures?
Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ Geriatrics ★★★★★☆☆ Rheumatology ★★★★★★☆
randomised controlled trial.
blinded (patients and healthcare providers).*
Follow up period:
72 centres in 11 European countries and Australia.
1649 women who were ⩾50 years of age (mean age 69 y) and had been postmenopausal for ⩾5 years, had ⩾1 fracture confirmed by spinal radiography, and had a lumbar spine bone mineral density (BMD) ⩽0.840 g/cm2. Exclusion criteria were severe diseases or conditions that could interfere with bone metabolism or use of antiosteoporotic treatments (fluoride salts and bisphosphonates, oestrogen, calcitonin, or calcitriol).